Description: ImmuCell Corporation engages in the acquisition, development, manufacture, and sale of products that enhance the health and productivity of cows for the dairy and beef industries in the United States and internationally. The company offers First Defense, an orally delivered scours preventive product for newborn calves; Wipe Out Dairy Wipes, which consist of biodegradable towelettes that are pre-moistened with a Nisin-based formulation to prepare the teat area of a cow in advance of milking; and California Mastitis Test that is performed at cow-side for early detection of mastitis. It is also developing Mast Out, an intramammary product for the treatment of subclinical mastitis in lactating dairy cows; therapies that prevent scours in calves caused by enteric pathogens other than E. coli K99 and bovine coronavirus; and various product applications of its First Defense technology. The company sells its products to distributors and bovine veterinarians, as well as directly to dairy producers. ImmuCell Corporation was founded in 1982 and is based in Portland, Maine.
Home Page: immucell.com
ICCC Technical Analysis
56 Evergreen Drive
Portland,
ME
04103
United States
Phone:
207 878 2770
Officers
Name | Title |
---|---|
Mr. Michael F. Brigham | Pres, CEO, Principal Financial Officer, Treasurer, Sec. & Director |
Ms. Bobbi Jo Brockmann | VP of Sales & Marketing and Director |
Ms. Elizabeth L. Williams | VP of Manufacturing Operations |
Elizabeth S. Toothaker | Director of Fin. & Admin. |
Mr. A. Gustavo Scaffa | Sr. Director of Quality |
John W. Zinckgraf | Director of Product Devel. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Biotechnology |
GIC Sub-Industry: | Biotechnology |
Forward PE: | 0 |
---|---|
Trailing PE: | 160 |
Price-to-Book MRQ: | 1.5962 |
Price-to-Sales TTM: | 2.5128 |
IPO Date: | 1987-04-30 |
Fiscal Year End: | December |
Full Time Employees: | 64 |